2017 Researcher Tommy Alain

"Characterization of a New Pharmaco-Viral Approach for the Treatment of Brain Cancer"

Tommy Alain
Scientist – Children’s Hospital of Eastern Ontario Research Institute (CHEO RI)
Assistant professor – University of Ottawa

Project Summary:

Tommy Alain - 2017 Research Grant Recipient

Brain tumours, particularly glioblastoma multiforme, have limited therapeutic options. New therapies are needed against this almost universally fatal cancer. 

In recent years, scientists have developed approaches that involve the use of common viruses to reactivate the immune system within patients to enable it to recognize and eliminate cancer cells. 

In our laboratory, we are testing the ability of the herpes simplex virus (HSV1) to infect various cancer cell types. Recently, we have identified a chemical anti-cancer agent that dramatically enhances the ability of the virus to propagate inside brain cancer cells but not inside normal cells. 

In this study, we propose to investigate how this agent works to promote the replication of this virus. Understanding this process we believe will provide valuable insight for the development of HSV1-based anti-cancer therapeutics.
 

Read more about Tommy Alain
 

Project Update:

Oncolytic viruses are unique immunotherapeutic agents for the treatment of cancer, but their replication within tumour tissue is limited. We have discovered a novel drug that strongly boost oncolytic virus replication within cancer cells. We proposed to study the mechanism of action of this molecule and how this pharmaco-viral combination could improve murine models of brain cancer. We have found that administering this drug to tumour bearing mice prior to injection with oncolytic viruses resulted in a dramatic increase in viral spread within tumour tissues. We now are studying these processes carefully both in brain cancer cell lines and murine models of glioblastoma. Read more from this project update...

< Back to all 2017 Research Grant Awardees 

Share This

Featured Story

Make every brain tumour count

Stephanie, a 38-year-old mother of twins has been diagnosed with an extremely rare and inoperable brain tumour - a rosette-forming glioneuronal tumour, a type of tumour that little is known about and cannot be removed due to its location in her brain. This reality does not stop Stephanie from her tireless efforts to reduce the stigma of having a brain tumour. Learn why Stephanie is urging all Canadians to make every brain tumour count.

Learn more

Spotlight

Piper's Story: a dream more precious than Olympic gold

Hi, I am Piper Gilles. You may know me as a world-famous ice dancer. I competed in the PyeongChang 2018 Olympic Winter Games. I am a 7...

Learn more

Doug's Adventure

I am Doug, I have brain cancer; I am told it is terminal, but the “good” kind of terminal. I can assure you that receiving that news...

Learn more

Upcoming Events

  • 19/Aug/2019: Virtual Support Group for Caregivers (Eastern Canada): Virtual Support Group for Caregivers (Eastern Canada)... Learn more >
  • 20/Aug/2019: Groupe de soutien virtuel: Un groupe de soutien virtuel pour personnes touchées par une tumeur... Learn more >
  • 21/Aug/2019: Niagara Region Support Group: Meets at Wellspring Niagara, 3250 Schmon Parkway, Thorold, ON, L2V 4Y6... Learn more >
  • 26/Aug/2019: Greater Sudbury Support Group: Meets at The Parkside Centre, 140 Durham Street, Sudbury, Ontario... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2019 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001